DB
Beran, David Henri
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Role of biosimilar introduction on insulin glargine prices : a retrospective analysis in 28 European countries | BMJ open |  | 2025 | 30 | 9 | ||
| Characterising acute and chronic care needs : insights from the Global Burden of Disease Study 2019 | Nature communications | | 2025 | 36 | 304 | ||
| Adapting and Accepting Type 1 Diabetes: A Qualitative Exploration of the Perspectives from People with Type 1 Diabetes from 13 Countries | Healthcare | | 2025 | 39 | 36 | ||
| Patient relevant outcomes for type 1 diabetes management : A qualitative evidence synthesis | Diabetic medicine |  | 2025 | 23 | 0 | ||
| Development of a target product profile for new glucose self-monitoring technologies for use in low- and middle-income countries | PloS one | | 2024 | 32 | 33 | ||
| The Lancet Diabetes & Endocrinology Commission on type 1 diabetes : looking back to move forward | The Lancet. Diabetes & endocrinology | | 2024 | 38 | 0 | ||
| Co-creation process of an intervention to implement a multiparameter point-of-care testing device in a primary healthcare setting for non-communicable diseases in Peru | BMC health services research | | 2024 | 30 | 50 | ||
| Ensuring sexual and reproductive healthcare services amidst a pandemic : Experiences from health workers in Lima, Peru | PLOS global public health | | 2024 | 27 | 63 | ||
| User requirements for non-invasive and minimally invasive glucose self-monitoring devices in low-income and middle-income countries : a qualitative study in Kyrgyzstan, Mali, Peru and Tanzania | BMJ open | | 2024 | 28 | 21 | ||
| Availability, price and affordability of insulin, delivery devices and self-monitoring blood glucose devices in Indonesia | PloS one | | 2024 | 27 | 278 | ||
| Lack of access to insulin : undermining the Rights of the Child | The Lancet. Diabetes & endocrinology | | 2024 | 30 | 21 | ||
| Involving different stakeholders in prioritising outcomes to assess healthcare systems response for type 1 diabetes management : Using co-creation approaches in Peru | The International journal of health planning and management | | 2024 | 38 | 47 | ||
| Outcomes measured in studies assessing health systems interventions for type 1 diabetes management : A scoping review | Diabetic medicine | | 2024 | 49 | 35 | ||
| Human resources challenges in the management of diabetes and hypertension in Mozambique | PloS one | | 2024 | 36 | 53 | ||
| International Day of Charity : what does charity mean for diabetes ? | The Lancet. Diabetes & endocrinology | | 2024 | 23 | 0 | ||
| White Book on type 1 Diabetes in Denmark | | 2023 | 530 | 325 | |||
| A plan to improve global type 1 diabetes epidemiology data | The Lancet. Diabetes & endocrinology | | 2023 | 76 | 70 | ||
| Using Clinical Vignettes to Understand the Complexity of Diagnosing Type 1 Diabetes in Sub-Saharan Africa | Research and reports in tropical medicine | | 2023 | 18 | 13 | ||
| Exploring key-stakeholder perceptions on non-communicable disease care during the COVID-19 pandemic in Kenya | The Pan African medical journal | | 2023 | 277 | 58 | ||
| Addressing Non-Communicable Diseases in Primary Healthcare in Kyrgyzstan : A Study on Population' Knowledge and Behavioral Changes | International journal of public health | | 2023 | 117 | 77 | ||
| Type 1 Diabetes and Health Information Systems : Lessons from Denmark | European medical journal. Diabetes | | 2023 | 31 | 16 | ||
| The Burden of Type 1 and Type 2 Diabetes Among Adolescents and Young Adults in 24 Western European Countries, 1990-2019 : Results From the Global Burden of Disease Study 2019 | International journal of public health | | 2023 | 32 | 31 | ||
| An Empirical Review of Key Glucose Monitoring Devices: Product Iterations and Patent Protection | Journal of diabetes science and technology | | 2023 | 158 | 215 | ||
| The role of nurses in diabetes care: challenges and opportunities | The Lancet. Diabetes & endocrinology | | 2023 | 84 | 0 | ||
| Implementation of a salt substitute intervention using social marketing in resourced-limited communities in Peru: a process evaluation study | Frontiers in public health | | 2023 | 102 | 54 | ||
| An Online Survey of the Perceptions of Clinical and Non-Clinical Professionals on Healthcare for Non-Communicable Diseases and COVID-19 Measures During the Pandemic in Malaysia | International journal of public health | | 2023 | 124 | 60 | ||
| Exploring medical students’ perceptions of family medicine in Kyrgyzstan: a mixed method study | BMC medical education | | 2023 | 130 | 114 | ||
| Accès à l’insuline : le(s) rôle(s) des gouvernements | Médecine des maladies métaboliques | | 2023 | 66 | 0 | ||
| A study is 21 times more likely to find unfavourable results about the nutrition label Nutri-Score if the authors declare a conflict of interest or the study is funded by the food industry | BMJ global health | | 2023 | 146 | 57 | ||
| The role of non-governmental organizations in strengthening healthcare systems in low- and middle-income countries: Lessons from Santé Diabète in Mali | Global health action | | 2022 | 200 | 151 | ||
| Using government data to understand the use and availability of medicines for hypertension and diabetes: lessons from Peru | Journal of pharmaceutical policy and practice | | 2022 | 92 | 70 | ||
| Management of type 1 diabetes in low‐ and middle‐income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania | Diabetic medicine | | 2022 | 224 | 122 | ||
| Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019 | The Lancet. Child & adolescent health | | 2022 | 177 | 120 | ||
| COVID‐19's impact on type 1 diabetes management : A mixed‐methods study exploring the Peruvian experience | The International journal of health planning and management | | 2022 | 36 | 75 | ||
| ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes | Pediatric diabetes | | 2022 | 178 | 0 | ||
| Changes in prevalence and the cascade of care for type 2 diabetes over ten years (2005-2015): results of two nationally representative surveys in Mozambique | BMC public health | | 2022 | 100 | 39 | ||
| Caring for people with diabetes and non-communicable diseases in Ukraine: a humanitarian emergency | The Lancet. Diabetes & endocrinology | | 2022 | 493 | 3 | ||
| Diabetes and the WHO Model List of Essential Medicines | The Lancet. Diabetes & endocrinology | | 2022 | 166 | 0 | ||
| The insulin market reaches 100 | Diabetologia | | 2022 | 165 | 114 | ||
| Health system responses for type 1 diabetes: A scoping review | Diabetic medicine | | 2022 | 216 | 507 | ||
| Strategies to address non-communicable diseases in the Commonwealth of Independent States countries: a scoping review | Primary health care research & development | | 2022 | 83 | 54 | ||
| Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 | The Lancet. Diabetes & endocrinology | | 2022 | 166 | 184 | ||
| EXTending availability of self-management structured EducatioN programmes for people with type 2 Diabetes in low-to-middle income countries (EXTEND) - a feasibility study in Mozambique and Malawi | BMJ open | | 2021 | 339 | 235 | ||
| Reforms in medical education: lessons learnt from Kyrgyzstan | Global Health Action | | 2021 | 300 | 267 | ||
| Beyond the virus: Ensuring continuity of care for people with diabetes during COVID-19 | Primary Care Diabetes | | 2021 | 402 | 162 | ||
| To tackle diabetes, science and health systems must take into account social context | Nature Medicine | | 2021 | 219 | 89 | ||
| Process evaluation of complex interventions in chronic and neglected tropical diseases in low- and middle-income countries—a scoping review protocol | Systematic reviews | | 2021 | 214 | 113 | ||
| Use of the socio-ecological model to explore factors that influence the implementation of a diabetes structured education programme (EXTEND project) inLilongwe, Malawi and Maputo, Mozambique: a qualitative study | BMC Public Health | | 2021 | 286 | 219 | ||
| Operational considerations for the management of non-communicable diseases in humanitarian emergencies | Conflict and Health | | 2021 | 281 | 165 | ||
| Why are individuals with diabetes less active? The mediating role of physical, emotional, and cognitive factors | Annals of Behavioral Medicine | | 2021 | 261 | 1 | ||
| Development of a target product profile for a point-of-care cardiometabolic device | BMC cardiovascular disorders | | 2021 | 158 | 270 | ||
| Failing to address access to insulin in its centenary year would be a catastrophic moral failure | The Lancet Diabetes & Endocrinology | | 2021 | 213 | 0 | ||
| Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care | PLOS ONE | | 2021 | 387 | 276 | ||
| Access to antivenoms in the developing world: A multidisciplinary analysis | Toxicon X | | 2021 | 325 | 347 | ||
| Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults | Diabetologia | | 2021 | 233 | 294 | ||
| Forty years after Alma-Ata: primary health-care preparedness for chronic diseases in Mozambique, Nepal and Peru | Global health action. Supplement | | 2021 | 220 | 130 | ||
| How to bring research evidence into policy? Synthesizing strategies of five research projects in low-and middle-income countries | Health Research Policy and Systems | | 2021 | 228 | 226 | ||
| Diagnostics and monitoring tools for noncommunicable diseases: a missing component in the global response | Globalization and health | | 2021 | 191 | 159 | ||
| Rethinking research processes to strengthen co-production in low and middle income countries | BMJ | | 2021 | 243 | 70 | ||
| A global perspective on the issue of access to insulin | Diabetologia | | 2021 | 268 | 228 | ||
| Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis | The Lancet. Diabetes & endocrinology. | | 2021 | 229 | 0 | ||
| Technologies for Diabetes Self-Monitoring: A Scoping Review and Assessment Using the REASSURED Criteria | Journal of diabetes science and technology | | 2021 | 195 | 126 | ||
| Precision global health: a roadmap for augmented action | Journal of Public Health and Emergency | | 2020 | 990 | 370 | ||
| Lessons learned about co-creation: developing a complex intervention in rural Peru | Global Health Action | | 2020 | 408 | 152 | ||
| Social marketing interventions for the prevention and control of neglected tropical diseases: A systematic review | PLOS Neglected Tropical Diseases | | 2020 | 299 | 265 | ||
| Towards the real-time inclusion of sex- and age-disaggregated data in pandemic responses | BMJ global health | | 2020 | 91 | 36 | ||
| Spotlight on experiences of medicine unavailability: access to medicines challenges for NCDs and NTDs - the contrasting cases of insulin and praziquantel | Expert Review of Clinical Pharmacology | | 2020 | 291 | 2 | ||
| Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria | Tropical Medicine & International Health | | 2020 | 259 | 1 | ||
| Recommendations for the use of mathematical modelling to support decision‐making on integration of non‐communicable diseases into HIV care | Journal of the International AIDS society | | 2020 | 321 | 108 | ||
| Report of the WHO independent high-level commission on NCDs: where is the focus on addressing inequalities? | BMJ (Global health) | | 2020 | 249 | 146 | ||
| Global Inequality in Type 1 Diabetes: a Comparison of Switzerland and Low-and Middle-Income Countries | Pediatric endocrinology reviews : PER |  | 2020 | 376 | 0 | ||
| Disruption, changes, and adaptation: Experiences with chronic conditions in Mozambique, Nepal and Peru | Global Public Health | | 2020 | 244 | 172 | ||
| The process of building the priority of neglected tropical diseases: A global policy analysis | PLOS Neglected Tropical Diseases | | 2020 | 290 | 188 | ||
| Precios, disponibilidad y asequibilidad de insulina en farmacias públicas y privadas en Perú | Revista panamericana de salud pública | | 2019 | 333 | 161 | ||
| Analogue insulin as an essential medicine: the need for more evidence and lower prices | The Lancet Diabetes & Endocrinology | | 2019 | 276 | 2 | ||
| What is innovation in the area of medicines? The example of insulin and diabetes | Diabetic Medicine | | 2019 | 229 | 1 | ||
| Challenges associated with providing diabetes care in humanitarian settings | The Lancet Diabetes & Endocrinology | | 2019 | 356 | 1 | ||
| Forty years since Alma-Ata: do we need a new model for noncommunicable diseases? | Journal of Global Health | | 2019 | 407 | 484 | ||
| Access to insulin: applying the concept of security of supply to medicines | Bulletin of the World Health Organization | | 2019 | 294 | 2 | ||
| High-quality health systems: time for a revolution in research and research funding | The Lancet Global Health | | 2019 | 391 | 160 | ||
| "If you will counsel properly with love, they will listen": A qualitative analysis of leprosy affected patients' educational needs and caregiver perceptions in Nepal | PLOS ONE | | 2019 | 442 | 268 | ||
| Estimation of global insulin use for type 2 diabetes, 2018–30: a microsimulation analysis | The Lancet Diabetes & Endocrinology | | 2019 | 288 | 1 | ||
| Insulin prices, availability and affordability in 13 low-income and middle-income countries | BMJ (Global health) | | 2019 | 370 | 207 | ||
| The process of prioritization of non-communicable diseases in the global health policy arena | Health Policy and Planning | | 2019 | 367 | 152 | ||
| Ability of verbal autopsy data to detect deaths due to uncontrolled hyperglycaemia: testing existing methods and development and validation of a novel weighted score | BMJ Open | | 2019 | 254 | 73 | ||
| Insulin price components: case studies in six low/middle-income countries | BMJ (Global health) | | 2019 | 360 | 175 | ||
| A perspective on global access to insulin: a descriptive study of the market, trade flows and prices | Diabetic Medicine | | 2019 | 369 | 185 | ||
| Noncommunicable diseases, access to essential medicines and universal health coverage | Global Health Action | | 2019 | 258 | 101 | ||
| Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries:a scoping review | BMC Public Health | | 2019 | 418 | 429 | ||
| The experience of the Santé Diabète NGO in the fight against diabetes in Africa | Médecine et santé tropicales | | 2018 | 330 | 0 | ||
| Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment | Current Diabetes Reports | | 2018 | 281 | 1 | ||
| Déclaration de Grenoble : la lutte contre les maladies non transmissibles, dont le diabète, une urgence sanitaire pour l'Afrique | Médecine et santé tropicales | | 2018 | 311 | 0 | ||
| Moving from formative research to co-creation of interventions: insights from a community health system project in Mozambique, Nepal and Peru | BMJ (Global health) | | 2018 | 351 | 131 | ||
| Self-management of diabetes in Sub-Saharan Africa: a systematic review | BMC Public Health | | 2018 | 296 | 158 | ||
| Accès aux soins et aux traitements pour le diabète en Afrique : défis et opportunités | Médecine et santé tropicales | | 2018 | 302 | 1 | ||
| The impact of chronic disease management on primary care doctors in Switzerland: a qualitative study | BMC Family Practice | | 2018 | 356 | 180 | ||
| Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective | Diabetes Care | | 2018 | 294 | 0 | ||
| Addressing the double-burden of diabetes and tuberculosis: lessons from Kyrgyzstan | Globalization and Health | | 2017 | 218 | 68 | ||
| Bringing all together for research capacity building in LMICs – Authors' reply | The Lancet Global Health | | 2017 | 262 | 72 | ||
| "My heart burns" - A qualitative study of perceptions and experiences of type 1 diabetes among children and youths in Tajikistan | Chronic Illness | | 2017 | 299 | 1 | ||
| The role of biosimilar manufacturers in improving access to insulin globally | The Lancet Diabetes & Endocrinology | | 2017 | 228 | 0 | ||
| Diabetes in sub-Saharan Africa: from clinical care to health policy | The Lancet Diabetes & Endocrinology | | 2017 | 261 | 3 | ||
| Modifying the Interagency Emergency Health Kit to include treatment for non-communicable diseases in natural disasters and complex emergencies: the missing clinical, operational and humanitarian perspectives | BMJ (Global health) | | 2017 | 281 | 135 | ||
| Research capacity building—obligations for global health partners | The Lancet Global Health | | 2017 | 218 | 72 | ||
| Non-communicable diseases in humanitarian settings: ten essential questions | Conflict and Health | | 2017 | 398 | 136 | ||
| Towards sustainable partnerships in global health: the case of the CRONICAS Centre of Excellence in Chronic Diseases in Peru | Globalization and Health | | 2016 | 230 | 114 | ||
| Integrated health systems for chronic disease management: lessons from Type 1 diabetes in Low Income Settings | | 2016 | 649 | 326 | |||
| Access to essential medicines to treat chronic respiratory disease in low-income countries | International Journal of Tuberculosis and Lung Disease | | 2016 | 235 | 0 | ||
| Coping with the economic burden of Diabetes, TB and co-prevalence: evidence from Bishkek, Kyrgyzstan | BMC Health Services Research | | 2016 | 433 | 174 | ||
| Insulin patents and market exclusivities: unresolved issues | The Lancet Diabetes & Endocrinology | | 2016 | 207 | 0 | ||
| The need to focus on primary health care for chronic diseases | The Lancet Diabetes & Endocrinology | | 2016 | 243 | 2 | ||
| Constraints and challenges in access to insulin: a global perspective | The Lancet Diabetes & Endocrinology | | 2016 | 257 | 1 | ||
| Insulin in 2016: Challenge and constraints to access | Diabetes Research and Clinical Practice | | 2016 | 240 | 1 | ||
| Professional medical associations in low-income and middle-income countries | The Lancet Global Health | | 2016 | 226 | 94 | ||
| Delivery of Type 2 diabetes care in low- and middle-income countries: lessons from Lima, Peru | Diabetic Medicine | | 2016 | 234 | 1 | ||
| Medicines availability for non-communicable diseases: the case for standardized monitoring | Globalization and health | | 2015 | 600 | 273 | ||
| Diabetes in an emergency context: the Malian case study | Conflict and health | | 2015 | 630 | 239 | ||
| Endemic diabetes in the world's poorest people | The Lancet. Diabetes & endocrinology | | 2015 | 595 | 4 | ||
| Health systems research for policy change: lessons from the implementation of rapid assessment protocols for diabetes in low- and middle-income settings | Health research policy and systems | | 2015 | 578 | 174 | ||
| In defence of NICE draft type 2 diabetes guidelines | The Lancet Diabetes & Endocrinology | | 2015 | 210 | 0 | ||
| Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries | The Lancet. Respiratory medicine | | 2015 | 702 | 3 | ||
| The Impact of Health Systems on Diabetes Care in Low and Lower Middle Income Countries | Current Diabetes Reports | | 2015 | 193 | 0 | ||
| Improving global access to medicines for non-communicable diseases | The Lancet Global Health | | 2014 | 206 | 79 | ||
| Use and Out-of-Pocket Costs of Insulin for Type 2 Diabetes Mellitus From 2000 Through 2010 | JAMA (Journal of the American Medical Association) | | 2014 | 211 | 0 | ||
| Developing a hierarchy of needs for Type 1 diabetes | Diabetic Medicine | | 2014 | 253 | 1 | ||
| The double scandal of insulin | The Journal of the Royal College of Physicians of Edinburgh | | 2013 | 252 | 132 | ||
| Santé globale à l'Université de Genève : Cartographie des activités, mai 2012 | | 2013 | 841 | 33 | |||
| Diabetes in Kyrgyzstan: changes between 2002 and 2009 | The International journal of health planning and management | | 2013 | 617 | 2 | ||
| Global Reality of Type 1 Diabetes Care in 2013 | Diabetes Care | | 2013 | 204 | 91 | ||
| Chronic conditions: lessons from the frontlines | Chronic illness | | 2013 | 573 | 2 | ||
| Non-communicable diseases in Mozambique: risk factors, burden, response and outcomes to date | Globalization and health | | 2012 | 704 | 634 | ||
| Promoting the use of DPP-4 inhibitors in Asia | Diabetes research and clinical practice | | 2012 | 512 | 1 | ||
| On the road to the insulin centenary | Lancet | | 2012 | 507 | 1 | ||
| The International Diabetes Federation: losing its credibility by partnering with Nestlé? | Lancet | | 2012 | 662 | 3 | ||
| Health systems and the management of chronic diseases: lessons from Type 1 diabetes | Diabetes management | 2012 | 643 | 0 | |||
| The insulin dilemma in resource-limited countries. A way forward ? | Diabetologia | | 2011 | 8 | 5 | ||
| Twinning for better diabetes care: a model for improving healthcare for non-communicable diseases in resource-poor countries | Postgraduate medical journal | | 2009 | 5 | 0 | ||
| Assessing health systems for type 1 diabetes in sub-Saharan Africa: developing a 'Rapid Assessment Protocol for Insulin Access' | BMC health services research | | 2006 | 174 | 62 | ||
| Diabetes care in sub-Saharan Africa | Lancet | | 2006 | 207 | 0 |
